NIGRO, Gerardo
 Distribuzione geografica
Continente #
EU - Europa 12.906
NA - Nord America 7.330
AS - Asia 5.490
SA - Sud America 908
Continente sconosciuto - Info sul continente non disponibili 476
AF - Africa 69
OC - Oceania 5
Totale 27.184
Nazione #
RU - Federazione Russa 7.958
US - Stati Uniti d'America 7.136
SG - Singapore 2.057
IE - Irlanda 1.357
CN - Cina 1.140
IT - Italia 983
HK - Hong Kong 894
BR - Brasile 766
VN - Vietnam 667
FR - Francia 617
GB - Regno Unito 527
DE - Germania 483
UA - Ucraina 395
KR - Corea 250
SE - Svezia 183
IN - India 164
FI - Finlandia 123
GR - Grecia 116
CA - Canada 80
AR - Argentina 63
JP - Giappone 63
TR - Turchia 62
MX - Messico 40
ID - Indonesia 34
AT - Austria 32
NL - Olanda 27
BD - Bangladesh 26
IQ - Iraq 23
ZA - Sudafrica 23
EC - Ecuador 21
BE - Belgio 20
PL - Polonia 20
CZ - Repubblica Ceca 16
JM - Giamaica 14
CO - Colombia 12
EG - Egitto 12
HN - Honduras 12
UZ - Uzbekistan 12
CL - Cile 11
ES - Italia 11
TH - Thailandia 11
AE - Emirati Arabi Uniti 10
PK - Pakistan 10
PY - Paraguay 10
MA - Marocco 9
SA - Arabia Saudita 9
CH - Svizzera 8
CR - Costa Rica 8
VE - Venezuela 8
BO - Bolivia 7
KE - Kenya 7
NI - Nicaragua 7
TT - Trinidad e Tobago 7
EU - Europa 5
JO - Giordania 5
LB - Libano 5
PH - Filippine 5
PS - Palestinian Territory 5
SV - El Salvador 5
UY - Uruguay 5
AL - Albania 4
BG - Bulgaria 4
MY - Malesia 4
PE - Perù 4
QA - Qatar 4
TN - Tunisia 4
AU - Australia 3
AZ - Azerbaigian 3
BH - Bahrain 3
DZ - Algeria 3
EE - Estonia 3
ET - Etiopia 3
GT - Guatemala 3
IL - Israele 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NO - Norvegia 3
PR - Porto Rico 3
PT - Portogallo 3
RO - Romania 3
TW - Taiwan 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BS - Bahamas 2
CI - Costa d'Avorio 2
CY - Cipro 2
DO - Repubblica Dominicana 2
HT - Haiti 2
LT - Lituania 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
RS - Serbia 2
SC - Seychelles 2
SI - Slovenia 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
Totale 26.702
Città #
Moscow 2.862
Dublin 1.353
Santa Clara 991
Hong Kong 877
Singapore 820
Ashburn 654
Jacksonville 654
San Jose 654
Council Bluffs 556
Chandler 518
Seoul 245
Ho Chi Minh City 212
Princeton 205
Hefei 189
Hanoi 167
Medford 155
Milan 155
Bremen 147
Roxbury 145
Beijing 130
Dallas 110
Bengaluru 97
Ann Arbor 86
The Dalles 83
Wilmington 83
Boardman 78
Naples 76
New York 66
São Paulo 66
San Mateo 63
Caserta 56
Da Nang 52
Miano 46
Cambridge 45
Des Moines 45
Nuremberg 44
Woodbridge 44
Munich 43
Los Angeles 41
Rome 40
North Bergen 35
Falkenstein 34
Haiphong 34
Belo Horizonte 33
Atlanta 32
Phoenix 28
Chicago 26
Guangzhou 26
Orem 26
Jinan 25
Nanjing 23
Aversa 22
Houston 21
Düsseldorf 20
Nanchang 20
Rio de Janeiro 20
Frankfurt am Main 19
Brussels 18
Tianjin 18
Tokyo 18
Mountain View 17
Helsinki 16
Brooklyn 15
Norwalk 15
Hangzhou 14
London 14
Mexico City 14
Montreal 14
Shenyang 14
Warsaw 14
Zhengzhou 14
Brasília 13
Brno 13
Changsha 13
Toronto 13
Amsterdam 12
Hebei 12
Kochi 12
Manchester 12
Redwood City 12
Biên Hòa 11
Carrboro 11
Columbus 11
Denver 11
Florence 11
Guarulhos 11
Lanzhou 11
Memphis 11
Mumbai 11
Philadelphia 11
Shanghai 11
Turku 11
Vienna 11
Chennai 10
Marano Di Napoli 10
Napoli 10
Ninh Bình 10
Porto Alegre 10
Salvador 10
Taizhou 10
Totale 13.937
Nome #
A longitudinal study on BIO14.6 hamsters with dilated cardiomyopathy: Micro-echocardiographic evaluation 193
Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes 187
Cardiovascular Involvement in mtDNA Disease: Diagnosis, Management, and Therapeutic Options 176
Short-duration head-up tilt test potentiated with sublingual nitroglycerin in suspected vasovagal syncope: the fast Italian protocol 175
ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies 173
Ambulatory dynamic Holter monitoring: a practical guide to appropriate use and reporting in clinical cardiology 173
P-wave duration and dispersion in patients with Emery-Dreifuss muscular dystrophy. 169
A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience 167
Arrhythmic CArdiac DEath in MYotonic dystrophy type 1 patients (ACADEMY 1) study: the predictive role of programmed ventricular stimulation 166
Anaesthesia and Rare Neuromuscular Diseases 163
Autonomic nervous system imbalance and left ventricular systolic dysfunction as potential candidates for arrhythmogenesis in Becker muscular dystrophy 163
Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry 163
Increased heterogenity of ventricular repolarization in obese nonhypertensive children 160
Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients? 159
Arrhythmias and sudden cardiac death in beta-thalassemia major patients: Noninvasive diagnostic tools and early markers 158
Regional and transmural dispersion of repolarisation in patients with Emery-Dreifuss muscular dystrophy. 157
P dispersion: a new electrocardiographic parameter to evaluate the risk of atrial arrhythmias in Emery-Dreifuss muscular dystrophies 157
Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results 156
Apixaban in a morbid obese patient with atrial fibrillation: A clinical experience using the plasmatic drug evaluation 156
Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. 155
Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study 154
Novel mutations in LMNA A/C gene and associated phenotypes 154
Cardiomyopathies associated with Muscular Dystrophies 154
Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients 154
Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy 152
The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. 151
The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population. 151
Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. 150
Dispersion of repolarization and beta-thalassemia major: the prognostic role of QT and JT dispersion for identifying the high-risk patients for sudden death 149
Paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: P wave duration and dispersion analysis. 148
Which hemodynamic parameter predicts nitroglycerin-potentiated head-up tilt test response? 148
Optimal site for atrial lead implantation in myotonic dystrophy patients: the role of Bachmann's Bundle stimulation 148
Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. 148
Adenosine-induced sinus tachycardia in a patient with Myotonic Dystrophy type 1. 147
Remote monitoring of implantable cardiac monitors in patients with unexplained syncope: Predictors of false‐positive alert episodes 144
DUAL PATHWAY INHIBITION WITH RIVAROXABAN AND ASPIRIN REDUCES INFLAMMATORY BIOMARKERS IN ATHEROSCLEROSIS 144
Ablate and pace: Comparison of outcomes between conduction system pacing and biventricular pacing 142
The Impact of Selection Criteria of Obese Patients on Evaluation of Heart Rate Variability Following Bariatric Surgery Weight Loss 142
Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex. 141
The main determinant of hypotension in nitroglycerine tilt-induced vasovagal syncope. 141
Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population 140
Right atrial preference pacing algorithm in the prevention of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients: a long term follow-up study. 139
Risk of arrhythmias in MYotonic Dystrophy: trial design of the RAMYD study 139
Far field R-wave sensing in Myotonic Dystrophy type 1: right atrial appendage versus Bachmann's bundle region lead placement. 139
La variabilità del ciclo R-R come indice predittivo di effetto sul ritmo cardiaco in soggetti professionalmente esposti ai campi elettromagnetici ELF 139
The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. 138
Which parameters describe the electrophysiological properties of successful slow pathway RF ablation in patients with common atrioventricular nodal reentrant tachycardia? 138
Disease rescue and increased lifespan in a model of cardiomyopathy and muscular dystrophy by combined AAV treatments 138
Familial dilated cardiomyopathy associated with the typical dystrophin BMD mutation. Report on two additional cases 138
Advances in basic and clinical research in laminopathies. 137
Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene 137
Arrhythmic risk evaluation in myotonic dystrophy: the importance of selection criteria and methodological approach 135
Device-Related Complications and Inappropriate Therapies Among Subcutaneous vs. Transvenous Implantable Defibrillator Recipients: Insight Monaldi Rhythm Registry 134
Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up. 134
Ginkgo biloba: an ancient tree with new arrhythmic side effects. 134
Arrhythmic risk in Steinert Disease 134
Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. 133
Evaluation of cardiac and respiratory involvement in sarcoglycanopathies 133
Evaluation of the antioxidant response in the plasma of healthy or hypertensive subjects after short-term exercise 133
Usefulness of Heart Rate Variability as a predictor of sudden cardiac death in muscular dystrophies 133
P3.14 New AAVs for the muscle gene therapy in sarcoglycan deficient animals 132
Appropriate ICD Interventions for Ventricular Arrhythmias Are Predicted by Higher Syntax Scores I and II in Patients with Ischemic Heart Disease 131
The effect of aortic coarctation surgical repair on QTc and JTc dispersion in severe aortic coarctation newborns: a short-term follow-up study. 130
Atrial Septal Aneurysms and Supraventricular Arrhythmias: The Role of Atrial Electromechanical Delay. 127
Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results 127
Asystole on loop recorder in patients with unexplained syncope and negative tilt testing: age distribution and clinical predictors 126
Rate and nature of complications with leadless transcatheter pacemakers compared with transvenous pacemakers: results from an Italian multicentre large population analysis 126
The QT dispersion in the risk stratification of sudden death in Becker patients 126
Heart involvement in Emery-Dreifuss muscular dystrophies: new parameters to detect early atrial fibrosis and vulnerability 126
Ventricular fibrillation induced by coagulating mode bipolar electrocautery during pacemaker implantation in Myotonic Dystrophy type 1 patient. 125
ST-segment displacement in Duchenne muscular dystrophy: myocardial necrosis or apoptosis? 124
Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdown 124
Idiopathic left ventricular tachycardia: Evidence of a his bundle 'bystander' participation 123
Risk of arrhythmia in type I Myotonic Dystrophy: the role of clinical and genetic variables 122
Clinical Performance of Apixaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Direct Electrical Current Cardioversion: A Prospective Propensity Score-Matched Cohort Study 122
Atrioventricular Interval Extension Is Highly Efficient in Preventing Unnecessary Right Ventricular Pacing in Sinus Node Disease: A Randomized Cross-Over Study Versus Dual- to Atrial Single-Chamber Mode Switch 122
Impact on All-Cause and Cardiovascular Mortality of Cardiac Implantable Electronic Device Complications: Results From the POINTED Registry 122
Cardioinhibitory syncope with asystole during nitroglycerin potentiated head up tilt test: prevalence and clinical predictors 121
Ischemic heart disease therapy in the elderly: Risk/benefit ratio 120
Prevalence and clinical predictors of vasodepressor syncope during head up tilt test 119
Serum Lipids, Inflammation, and the Risk of Atrial Fibrillation: Pathophysiological Links and Clinical Evidence 118
Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols 118
Is the value of QT dispersion a valid method to foresee the risk of sudden death? A study in Becker patients 117
Increased dispersion of ventricular repolarization in emery dreifuss muscular dystrophy patient 117
Improvement of survival in Duchenne Muscular Dystrophy: retrospective analysis of 835 patients 116
Long-term clinical outcomes of patients with drug-induced type 1 Brugada electrocardiographic pattern: A nationwide cohort registry study 115
Evaluation of thyroid dysfunction in patients with paroxysmal atrial fibrillation 115
HETEROGENEITY OF VENTRICULAR REPOLARIZATION IN SEVERE AORTIC COARCTATION NEWBORNS 114
La variabilità del ciclo R-R come indice predittivo di effetto sul ritmo cardiaco in soggetti professionalmente esposti a campi elettromagnetici ELF. Atti del 64° Congresso Nazionale SIMLII 113
Use of a lower dosage liver-Detargeted AAV vector to prevent hamster muscular dystrophy. 113
The role of the atrial electromechanical delay in predicting atrial fibrillation in beta-thalassemia major patients 113
Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients 113
Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study 112
Superselective cannulation of coronary sinus branch with telescopic system during left ventricular lead placement 111
X-Linked Emery-Dreifuss Muscular Dystrophy: Study Of X-Chromosome Inactivation and Its Relation with Clinical Phenotypes in Female Carriers. 111
Gender Differences in Atrial Fibrillation: From the Thromboembolic Risk to the Anticoagulant Treatment Response 110
Interazione tra campi elettromagnetici ELF e ritmo cardiaco in macchinisti di veicoli a trazione elettrica: ricerca di un indice predittivo di rischio aritmico 110
Diagnosis and Management of Atrial Fibrillation by Primary Care Physicians in Italy : A Retrospective, Observational Analysis. 110
Evaluation of Becker cardiomyopathy by Vest investigation 109
Effect of dual-chamber minimal ventricular pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: A prospective, randomized, single-blind, crossover study 109
Totale 13.772
Categoria #
all - tutte 98.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.689


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.183 0 0 0 48 400 4 10 36 43 191 96 355
2022/20232.296 222 43 23 175 263 160 7 111 1.204 21 37 30
2023/2024848 55 39 38 65 343 32 15 21 4 17 60 159
2024/20253.461 19 27 15 73 503 560 340 279 452 697 270 226
2025/202613.369 526 660 740 768 1.030 7.414 836 405 474 236 200 80
2026/20272.808 109 312 1.188 1.199 0 0 0 0 0 0 0 0
Totale 27.184